ライフサイエンスコーパス: Neisseria gonorrhoeae

1 ts Chlamydia trachomatis and "GC" represents Neisseria gonorrhoeae).

2 d persons infected with antibiotic-resistant Neisseria gonorrhoeae).

3 terial infections: Chlamydia trachomatis and Neisseria gonorrhoeae.

4 llows it to modulate biofilm accumulation by Neisseria gonorrhoeae.

5 ce and global spread of antibiotic-resistant Neisseria gonorrhoeae.

6 c inflammation that is insufficient to clear Neisseria gonorrhoeae.

7 l with substantial in vitro activity against Neisseria gonorrhoeae.

8 indistinguishable from infections caused by Neisseria gonorrhoeae.

9 to date has examined the effects of CrgA in Neisseria gonorrhoeae.

10 r survival and establishment of infection by Neisseria gonorrhoeae.

11 ases (LDHs) from the obligate human pathogen Neisseria gonorrhoeae.

12 ons due to suspected cephalosporin-resistant Neisseria gonorrhoeae.

13 o the fiber model of the type IVa pilin from Neisseria gonorrhoeae.

14 n complicated by antimicrobial resistance in Neisseria gonorrhoeae.

15 Gen-Probe Aptima assays for the detection of Neisseria gonorrhoeae.

16 arbon source for bacterial pathogens such as Neisseria gonorrhoeae.

17 ricted set of Gram-negative bacteria such as Neisseria gonorrhoeae.

18 dressed this question for the human pathogen Neisseria gonorrhoeae.

19 in the sexually transmitted disease pathogen Neisseria gonorrhoeae.

20 egative pathogens Pseudomonas aeruginosa and Neisseria gonorrhoeae.

21 neous detection of Chlamydia trachomatis and Neisseria gonorrhoeae.

22 etic exchange in the obligate human pathogen Neisseria gonorrhoeae.

23 fection by the sexually transmitted pathogen Neisseria gonorrhoeae.

24 m cephalosporins ceftriaxone and cefixime in Neisseria gonorrhoeae.

25 variable pilin locus of the human pathogen, Neisseria gonorrhoeae.

26 ortant source of antimicrobial resistance in Neisseria gonorrhoeae.

27 is active against an important eye pathogen, Neisseria gonorrhoeae.

28 stance for both Streptococcus pneumoniae and Neisseria gonorrhoeae.

29 ide KFF- NgH1 to target the same enzyme from Neisseria gonorrhoeae.

30 hape and dynamics of microcolonies formed by Neisseria gonorrhoeae.

31 pathogenesis of the closely related species, Neisseria gonorrhoeae.

32 ion and stable expression amongst strains of Neisseria gonorrhoeae.

33 he more common sexually transmitted pathogen Neisseria gonorrhoeae.

34 eningitidis isolate containing one copy of a Neisseria gonorrhoeae 16S rRNA gene is described herein.

35 s demonstrated with the analysis of clinical Neisseria gonorrhoeae 16S rRNA to show its potential val

36 We previously demonstrated that Neisseria gonorrhoeae, a Gram-negative pathogen responsi

37 resistance and diagnostic escape variants in Neisseria gonorrhoeae, a pathogen associated with a high

38 Neisseria gonorrhoeae (adjusted odds ratio [AOR], 1.75;

39 Mycoplasma genitalium was associated with Neisseria gonorrhoeae (adjusted OR, 1.84; 95% CI, 1.13-2

40 cillus crispatus, Gardnerella vaginalis, and Neisseria gonorrhoeae All vaginal microbiota and N. gono

41 Neisseria gonorrhoeae and Chlamydia trachomatis are well

42 lis by vaginal swabs; NAATs for detection of Neisseria gonorrhoeae and Chlamydia trachomatis from pha

43 ed amplification (TMA) enhances detection of Neisseria gonorrhoeae and Chlamydia trachomatis from rec

44 Pharyngeal and rectal Neisseria gonorrhoeae and Chlamydia trachomatis play imp

45 f patient gender, specimen source, molecular Neisseria gonorrhoeae and Chlamydia trachomatis results,

46 Genital tract infections caused by Neisseria gonorrhoeae and Chlamydia trachomatis serovars

47 , and urethral/first-void urine samples) for Neisseria gonorrhoeae and Chlamydia trachomatis using nu

48 simplex virus type 2, and were screened for Neisseria gonorrhoeae and Chlamydia trachomatis.

49 alternative pathway of complement, binds to Neisseria gonorrhoeae and constitutes an important mecha

50 e BAM complex, from two species of bacteria: Neisseria gonorrhoeae and Haemophilus ducreyi.

51 ly related bacteria, Neisseria meningitidis, Neisseria gonorrhoeae and Neisseria lactamica, which exh

52 Neisseria gonorrhoeae and Neisseria meningitidis are clo

53 Neisseria gonorrhoeae and Neisseria meningitidis are clo

54 terized pilin antigenic variation systems of Neisseria gonorrhoeae and Neisseria meningitidis is pres

55 an-adapted Neisseria includes two pathogens, Neisseria gonorrhoeae and Neisseria meningitidis, and at

56 Two human pathogens, Neisseria gonorrhoeae and Neisseria meningitidis, stimul

57 PNAG is also a capsular polysaccharide for Neisseria gonorrhoeae and nontypable Hemophilus influenz

58 ction of an intense inflammatory response by Neisseria gonorrhoeae and the persistence of this pathog

59 irth outcome (OR, 0.24; 95% 0.09, 0.66), and Neisseria gonorrhoeae and/or Chlamydia trachomatis had 9

60 ain (ATD) from the bifunctional enzyme PglB (Neisseria gonorrhoeae) and the full-length acetyltransfe

61 s, type-specific human papillomavirus (HPV), Neisseria gonorrhoeae, and HIV antibody.

62 on effect on incident Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium infecti

63 g Staphylococcus aureus, Bacillus anthracis, Neisseria gonorrhoeae, and Neisseria meningitidis.

64 fluoroquinolone-resistant Campylobacter spp, Neisseria gonorrhoeae, and Salmonella typhi were include

65 Positivity rates for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis DNA, de

66 ycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in liqu

67 M. genitalium and for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis Sequenc

68 e urine specimens for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis via com

69 In this study, we predicted Neisseria gonorrhoeae Ape1a to be an SGNH hydrolase with

70 a rates are rising, and antibiotic-resistant Neisseria gonorrhoeae (AR-Ng) is an urgent public health

71 to test the hypothesis that multiple pili of Neisseria gonorrhoeae are coordinated through a tug-of-w

72 Infections by Neisseria gonorrhoeae are increasingly common, are often

73 pic pregnancy, and Chlamydia trachomatis and Neisseria gonorrhoeae are recognized microbial causes.

74 Chlamydia trachomatis and Neisseria gonorrhoeae are the two most common causes of

75 Candida albicans, Gardnerella vaginalis, and Neisseria gonorrhoeae, as well as to toxic shock syndrom

76 y different NAATs (SDA, PCR, AC2, and Aptima Neisseria gonorrhoeae assay [AGC]; Gen-Probe Inc.).

77 The primary outcome was clearance of Neisseria gonorrhoeae at all initially infected sites, d

78 Neisseria gonorrhoeae bacteria are acknowledged as an ur

79 Microbe, Muenzner and Hauck (2020) find that Neisseria gonorrhoeae blocks exfoliation by producing ni

80 d method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no commercial tests are clear

81 d method to detect Chlamydia trachomatis and Neisseria gonorrhoeae, but no commercial tests are clear

82 has been used to investigate transmission of Neisseria gonorrhoeae, but to date, most studies have no

83 r the detection of Chlamydia trachomatis and Neisseria gonorrhoeae by a transcription-mediated amplif

84 s) can block complement-dependent killing of Neisseria gonorrhoeae by otherwise bactericidal Abs.

85 enome assemblies, we analyzed 25 isolates of Neisseria gonorrhoeae by using a high-resolution single

86 Infrequently, Neisseria gonorrhoeae can cause disseminated gonococcal

87 th the sexually transmitted disease pathogen Neisseria gonorrhoeae can either inhibit or induce apopt

88 Neisseria gonorrhoeae can engage human complement recept

89 The obligate human pathogen Neisseria gonorrhoeae carries one of the highest loads o

90 Most strains of Neisseria gonorrhoeae carry the 57-kb gonococcal genetic

91 Chlamydia trachomatis and Neisseria gonorrhoeae cases reached a record high in the

92 ria species two, Neisseria meningitidis, and Neisseria gonorrhoeae, cause invasive disease: the other

93 Neisseria gonorrhoeae causes gonorrhea, a sexually trans

94 The bacterium Neisseria gonorrhoeae causes the sexually transmitted in

95 , and nucleic acid amplification testing for Neisseria gonorrhoeae, Chlamydia trachomatis, and Tricho

96 STIs examined were laboratory-detected Neisseria gonorrhoeae, Chlamydia trachomatis, and Tricho

97 fic sexually transmitted infections, such as Neisseria gonorrhoeae, Chlamydia trachomatis, HIV, human

98 NGU was considered idiopathic when Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma

99 All participants were tested for Neisseria gonorrhoeae, Chlamydia trachomatis, Treponema

100 flexneri, and Campylobacter jejuni, but not Neisseria gonorrhoeae, cleaved E-cadherin on host cells.

101 the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae coinfections in U.S. women undergo

102 AGS) in the arginine biosynthetic pathway of Neisseria gonorrhoeae complexed with acetyl-CoA and with

103 Peptidoglycan fragments released by Neisseria gonorrhoeae contribute to the inflammation and

104 Neisseria gonorrhoeae culture is necessary to determine

105 Neisseria gonorrhoeae cultures were obtained at baseline

106 we performed a meta-analysis of seven large Neisseria gonorrhoeae datasets, as well as Klebsiella pn

107 Neisseria gonorrhoeae deploys a unique immune evasion st

108 ting, this study examined the persistence of Neisseria gonorrhoeae DNA following treatment for pharyn

109 o comprehensively examine the role of NER in Neisseria gonorrhoeae DNA recombination and repair proce

110 if Nanopore sequencing can detect sufficient Neisseria gonorrhoeae DNA to reconstruct whole genomes d

111 The human-restricted pathogen Neisseria gonorrhoeae encodes a single N-acetylmuramyl-l

112 in female mice to study mechanisms by which Neisseria gonorrhoeae evades host-derived antimicrobial

113 Neisseria gonorrhoeae expressing type IV pili (Tfp) acti

114 um and the homologous NgoAVII RM system from Neisseria gonorrhoeae FA1090 are composed of three genes

115 Neisseria gonorrhoeae forms a biofilm in flow cells on g

116 A redundancy of defenses may protect Neisseria gonorrhoeae from phagocyte-derived reactive ox

117 Gentamicin alone failed to eradicate Neisseria gonorrhoeae from the pharynx.

118 icated for evaluating UTI (E. coli) and STD (Neisseria gonorrhoeae) from human urine samples.

119 e III as predicted, whereas the hairpin from Neisseria gonorrhoeae functions as an intrinsic transcri

120 O-Acetylpeptidoglycan esterase from Neisseria gonorrhoeae functions to release O-acetyl grou

121 men who have receptive anal intercourse for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT

122 s quantified from rectal swabs collected for Neisseria gonorrhoeae (GC) and Chlamydia trachomatis (CT

123 Neisseria gonorrhoeae (Gc) is an obligate human pathogen

124 Neisseria gonorrhoeae (Gc), an obligate human bacterial

125 tal Chlamydia trachomatis (CT) and/or rectal Neisseria gonorrhoeae (GC).

126 on of HD5 and HD6 was induced in response to Neisseria gonorrhoeae (GC, for gonococcus) infection and

127 d three of the CDC approaches for confirming Neisseria gonorrhoeae (gonococcus [GC])-positive nucleic

128 rectal Chlamydia trachomatis (chlamydia) and Neisseria gonorrhoeae (gonorrhea) infections in women.

129 Neisseria gonorrhoeae has been shown to produce biofilms

130 Neisseria gonorrhoeae has developed resistance to each o

131 ns-acting sRNA in Neisseria meningitidis and Neisseria gonorrhoeae, has been shown in the meningococc

132 mophilus influenzae, Neisseria meningitidis, Neisseria gonorrhoeae, Helicobacter pylori, Moraxella ca

133 ctions of MMC in the obligate human pathogen Neisseria gonorrhoeae, homologues of the core MMC genes

134 mical analyses of Kingella denitrificans and Neisseria gonorrhoeae HpuA mutants, although validating

135 conditions, as well as in the human pathogen Neisseria gonorrhoeae identified HemN as a copper toxici

136 nd of the autotransporter beta-domain of the Neisseria gonorrhoeae IgA protease precursor (IgAbeta),

137 ased potency and showed its efficacy against Neisseria gonorrhoeae in a mouse vaginal infection model

138 cular detection of Chlamydia trachomatis and Neisseria gonorrhoeae in clinical samples.

139 -sensitive and cefixime-resistant strains of Neisseria gonorrhoeae in MSM in England, which was appli

140 ed a point-of-care test for the detection of Neisseria gonorrhoeae in patients attending a public hea

141 r the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in rectal swabs with regulatory ap

142 ltaneously detects Chlamydia trachomatis and Neisseria gonorrhoeae in swab and first-catch urine (FCU

143 produce hydrogen peroxide (H(2)O(2)) inhibit Neisseria gonorrhoeae in vitro, and clinical data sugges

144 Information on the innate response to Neisseria gonorrhoeae in women is limited to studies wit

145 n is associated with bacterial burden during Neisseria gonorrhoeae infection and alters the infection

146 point-of-care Gram stain testing to diagnose Neisseria gonorrhoeae infection and nongonococcal urethr

147 he main consequences of sexually transmitted Neisseria gonorrhoeae infection and probably involve an

148 imal methods for the diagnosis of pharyngeal Neisseria gonorrhoeae infection are uncertain.

149 Treatment of Neisseria gonorrhoeae infection is empirical and based o

150 Most oropharyngeal Neisseria gonorrhoeae infections are asymptomatic, and m

151 The majority of oropharyngeal Neisseria gonorrhoeae infections are asymptomatic, and m

152 acid amplification tests (NAATs) to diagnose Neisseria gonorrhoeae infections complicates the perform

153 osporins are the cornerstone of treatment of Neisseria gonorrhoeae infections, cefixime is the only o

154 g efficacious exposures for the treatment of Neisseria gonorrhoeae infections.

155 Neisseria gonorrhoeae is a common sexually transmitted p

156 Multidrug-resistant Neisseria gonorrhoeae is a global health problem.

157 Neisseria gonorrhoeae is a human-specific organism that

158 Antimicrobial resistance in Neisseria gonorrhoeae is a major issue of public health,

159 , understanding the evolutionary dynamics of Neisseria gonorrhoeae is a significant public and global

160 The rise of antimicrobial-resistant Neisseria gonorrhoeae is a significant public health con

161 Multidrug-resistant Neisseria gonorrhoeae is a top threat to public health.

162 Antimicrobial-resistant Neisseria gonorrhoeae is an emerging public health probl

163 The major outer membrane porin (PorB) of Neisseria gonorrhoeae is an essential protein that media

164 Neisseria gonorrhoeae is an obligate human pathogen that

165 Neisseria gonorrhoeae is an obligate human pathogen that

166 Neisseria gonorrhoeae is an urgent public health threat

167 Antimicrobial resistance (AMR) by Neisseria gonorrhoeae is considered a serious global thr

168 f the most frequent infectious diseases, and Neisseria gonorrhoeae is emerging as resistant to most a

169 ce and spread of antimicrobial resistance in Neisseria gonorrhoeae is globally recognised.

170 demonstrated that the strict human pathogen Neisseria gonorrhoeae is polyploid, carrying an average

171 The sexually transmitted pathogen Neisseria gonorrhoeae is regarded as being on the way to

172 chanisms of colonization and pathogenesis of Neisseria gonorrhoeae is required to aid development of

173 he O-linked protein glycosylation pathway in Neisseria gonorrhoeae is responsible for the synthesis o

174 Neisseria gonorrhoeae is the etiologic agent of gonorrhe

175 Gonorrhea, caused by the bacterium Neisseria gonorrhoeae, is a globally prevalent sexually

176 ea, a sexually transmitted disease caused by Neisseria gonorrhoeae, is an important cause of morbidit

177 The MtrCDE multidrug pump, from Neisseria gonorrhoeae, is assembled from the inner and o

178 We report on the first Neisseria gonorrhoeae isolate in the United States ident

179 In the United States, 19.2% of Neisseria gonorrhoeae isolates are resistant to ciproflo

180 Rising azithromycin nonsusceptibility among Neisseria gonorrhoeae isolates threatens current treatme

181 We identified a cluster of Neisseria gonorrhoeae isolates with high-level azithromy

182 Neisseria gonorrhoeae lipooligosaccharides (LOSs) induce

183 Neisseria gonorrhoeae may have contributed to complicati

184 The Neisseria gonorrhoeae MtrC-MtrD-MtrE multidrug-resistanc

185 ng the concurrence of Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, and Tricho

186 r Chlamydia trachomatis (C. trachomatis) and Neisseria gonorrhoeae (N. gonorrhoeae) infections.

187 accurately identify those with extragenital Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT

188 lines recommend the systematic screening for Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT

189 Urogenital testing misses extragenital Neisseria gonorrhoeae (NG) and Chlamydia trachomatis (CT

190 Neisseria gonorrhoeae (NG) infections are a global healt

191 antibiotic susceptibility testing (AST) for Neisseria gonorrhoeae (Ng) is critically needed to count

192 of these peptides to serve as substrates for Neisseria gonorrhoeae (NG) PBP3 was assessed.

193 ous detection of Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG), and an internal control in t

194 h a network-based mathematical model of HIV, Neisseria gonorrhoeae (NG), and Chlamydia trachomatis (C

195 compares the crystal structures of NAGS from Neisseria gonorrhoeae (ngNAGS) in the inactive T-state w

196 are sites of infection for the STD pathogen Neisseria gonorrhoeae (Ngo).

197 ic compound extrusion transporter, NorM from Neisseria gonorrhoeae (NorM_NG).

198 Several Neisseria gonorrhoeae nucleic acid amplification tests (

199 is, codetection of Chlamydia trachomatis and Neisseria gonorrhoeae occurred in 7.8% and 2.7% of healt

200 In Neisseria gonorrhoeae, one of the first bacteria for whi

201 rmed by laboratory isolation or detection of Neisseria gonorrhoeae only from a clinical specimen, and

202 l intercourse or were women at high risk for Neisseria gonorrhoeae or Chlamydia trachomatis infection

203 infections in prepubertal children, such as Neisseria gonorrhoeae or Chlamydia trachomatis, are due

204 d to be infected with Chlamydia trachomatis, Neisseria gonorrhoeae, or herpes simplex virus type 2.

205 also more prevalent among HIV-infected MSM (Neisseria gonorrhoeae, P = .03; Mycoplasma genitalium, P

206 Ps (the LMMA enzymes, Escherichia coli PBP5, Neisseria gonorrhoeae PBP4, and Streptococcus pneumoniae

207 ontal gene transfer between bacteria, and in Neisseria gonorrhoeae plasmids can mediate high-level an

208 jor outer membrane porin (PorB) expressed by Neisseria gonorrhoeae plays multiple roles during infect

209 The T4SS from Neisseria gonorrhoeae possesses the unique ability to me

210 The compound, CGS 15943, targets Neisseria gonorrhoeae PriA helicase with an IC(50) of 11

211 eins, we determined the crystal structure of Neisseria gonorrhoeae PriB at 2.7 A resolution and inves

212 Neisseria gonorrhoeae produces a type IV secretion syste

213 Neisseria gonorrhoeae produces no known siderophores but

214 BD ProbeTec Chlamydia trachomatis Q(x) (CTQ)/Neisseria gonorrhoeae Q(x) (GCQ), Hologic Aptima Combo 2

215 on MIC QC range for zoliflodacin against the Neisseria gonorrhoeae QC strain ATCC 49226 was defined a

216 Quinolone-resistant Neisseria gonorrhoeae (QRNG) arise from mutations in gyr

217 k in California of fluoroquinolone-resistant Neisseria gonorrhoeae (QRNG) by evaluation of a combinat

218 In Neisseria gonorrhoeae, recent work has revealed that Nsr

219 rol groups were immunized i.m. and s.c. with Neisseria gonorrhoeae recombinant porin B (Ng-rPorB) or

220 Both Neisseria meningitidis and Neisseria gonorrhoeae recruit the alternative pathway co

221 The human pathogen Neisseria gonorrhoeae recruits and interacts extensively

222 In contrast, the Neisseria gonorrhoeae RecX protein (RecX(Ng)) enhances a

223 Neisseria gonorrhoeae releases peptidoglycan (PG) fragme

224 Neisseria gonorrhoeae releases peptidoglycan fragments d

225 Neisseria gonorrhoeae releases peptidoglycan fragments d

226 The closely related pathogen Neisseria gonorrhoeae releases PG fragments during norma

227 Neisseria gonorrhoeae represents an urgent public health

228 Neisseria gonorrhoeae requires iron for survival in the

229 Increasing Neisseria gonorrhoeae resistance to ceftriaxone, the las

230 iptome analysis of the facultative anaerobe, Neisseria gonorrhoeae, revealed that many genes of unkno

231 ification test for Chlamydia trachomatis and Neisseria gonorrhoeae (Roche cobas 4800), a fully automa

232 experiments conducted with Escherichia coli, Neisseria gonorrhoeae, Salmonella enterica, Streptococcu

233 onal locations for Chlamydia trachomatis and Neisseria gonorrhoeae screening programs.

234 During infection, Neisseria gonorrhoeae senses and responds to stress; suc

235 Previous studies have demonstrated that Neisseria gonorrhoeae sialylates the terminal N-acetylla

236 We analyzed 265 urethral Neisseria gonorrhoeae specimens collected from symptomat

237 etect Chlamydia trachomatis AC2 also detects Neisseria gonorrhoeae Storage and temperature conditions

238 thogenic species, Neisseria meningitidis and Neisseria gonorrhoeae, straddle the border between comme

239 Opa(+) variants of Neisseria gonorrhoeae strain FA1090 are selected in a cy

240 All Neisseria gonorrhoeae strains whose DNA sequences have b

241 hea is expected to rise due to the spread of Neisseria gonorrhoeae strains with decreased susceptibil

242 , Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Streptococcus agalactiae, Chlamyd

243 Neisseria gonorrhoeae successfully overcomes host strate

244 of ceftriaxone, cefixime, and cefpodoxime in Neisseria gonorrhoeae surveillance.

245 e A (gyrA) genotypic assay for prediction of Neisseria gonorrhoeae susceptibility to ciprofloxacin.

246 hes of 24 samples; for Chlamydia trachomatis/Neisseria gonorrhoeae tests, the ability to run batches

247 Whereas the structure of Neisseria gonorrhoeae Tfp has been defined by convention

248 encodes a multidrug efflux pump possessed by Neisseria gonorrhoeae that is important in the ability o

249 ous problem with antimicrobial resistance in Neisseria gonorrhoeae that the public health system face

250 5 different antibiotics in 1,102 isolates of Neisseria gonorrhoeae that were confirmed in a second da

251 or Chlamydia trachomatis and "NG" stands for Neisseria gonorrhoeae) that uses the automated m2000 mol

252 against multidrug-resistant bacteria such as Neisseria gonorrhoeae The first structure of BamA, the c

253 The Neisseria gonorrhoeae (the gonococcus [Gc]) opacity-asso

254 d exclusively by the human-specific pathogen Neisseria gonorrhoeae (the gonococcus), is characterized

255 Neisseria gonorrhoeae (the gonococcus, Gc) triggers a po

256 Neisseria gonorrhoeae, the causative agent of gonorrhea,

257 Neisseria gonorrhoeae, the causative agent of gonorrhea,

258 s the gonococcal type IV pilus (GC-T4P) from Neisseria gonorrhoeae, the causative agent of gonorrhea.

259 been strongly implicated in the virulence of Neisseria gonorrhoeae, the causative agent of gonorrhea.

260 Neisseria gonorrhoeae, the causative agent of the sexual

261 Neisseria gonorrhoeae, the causative agent of the sexual

262 Neisseria gonorrhoeae, the cause of the sexually transmi

263 Neisseria gonorrhoeae, the etiologic agent of gonorrhea,

264 nce to azithromycin complicates treatment of Neisseria gonorrhoeae, the etiologic agent of gonorrhea.

265 In Neisseria gonorrhoeae, the ferric uptake regulator Fur r

266 parallel those of Chlamydia trachomatis and Neisseria gonorrhoeae, the mechanisms by which this path

267 In the beta-proteobacterium Neisseria gonorrhoeae, the native PilQ secretin ring emb

268 Neisseria gonorrhoeae, the sole causative agent of gonor

269 reasing azithromycin usage and resistance in Neisseria gonorrhoeae threatens current dual treatment.

270 fferent populations in the susceptibility of Neisseria gonorrhoeae to antimicrobials, and the reasons

271 The capacity of Neisseria gonorrhoeae to cause disseminated gonococcal i

272 Resistance of Neisseria gonorrhoeae to extended-spectrum cephalosporin

273 e sexually transmitted strict human pathogen Neisseria gonorrhoeae to mediators of the innate host de

274 ferrin-binding proteins TbpA and TbpB enable Neisseria gonorrhoeae to obtain iron from human transfer

275 blic health control; however, the ability of Neisseria gonorrhoeae to successively develop resistance

276 In this study, we used the type IV pilus of Neisseria gonorrhoeae to test whether variation of surfa

277 example, Candida albicans, Borrelia sp. and Neisseria gonorrhoeae) to generate surface protein diver

278 Salmonella enterica, Haemophilus ducreyi and Neisseria gonorrhoeae, together with BamA's homolog, Tam

279 rapid AST platform using RNA signatures for Neisseria gonorrhoeae Transcriptome sequencing (RNA-seq)

280 Molecular typing was used to elucidate Neisseria gonorrhoeae transmission networks among men wh

281 other STI organisms (Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis) and the E6

282 ed for M. genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Mycoplasma

283 We characterized the inhibition of Neisseria gonorrhoeae type II topoisomerases gyrase and

284 I (HepI) of the lipooligosaccharide (LOS) of Neisseria gonorrhoeae undergoes positive selection durin

285 Neisseria gonorrhoeae uses a type IV secretion system (T

286 Neisseria gonorrhoeae uses a type IV secretion system (T

287 were evaluated for Chlamydia trachomatis and Neisseria gonorrhoeae using NAATs and bacterial vaginosi

288 The strict human pathogen Neisseria gonorrhoeae utilizes homologous recombination

289 1 (ORF1) of the glutamine synthetase gene of Neisseria gonorrhoeae was able to tolerate urea concentr

290 lamydia trachomatis was detected in 8.7% and Neisseria gonorrhoeae was detected in 6.6%.

291 on antimicrobial resistance determinants in Neisseria gonorrhoeae was developed and is publicly acce

292 r the detection of Chlamydia trachomatis and Neisseria gonorrhoeae was established in a multisite, pr

293 he force-dependent velocity of DNA uptake by Neisseria gonorrhoeae We found that the DNA uptake veloc

294 Independent risk factors for oropharyngeal Neisseria gonorrhoeae were assessed among MSM routinely

295 Tests for Chlamydia trachomatis and Neisseria gonorrhoeae, which can provide results rapidly

296 Neisseria gonorrhoeae, which causes gonorrhea, is partic

297 nd to certain biological surfaces, including Neisseria gonorrhoeae, which facilitated C3 deposition.

298 nts such as human immunodeficiency virus and Neisseria gonorrhoeae with concurrent T. vaginalis infec

299 The emergence of Neisseria gonorrhoeae with decreased susceptibility to e

300 Survival of Neisseria gonorrhoeae within host epithelial cells is ex